Medicare Enrolled

Dr. Paul Finger, MD

Ophthalmology · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
115 E 61ST ST, New York, NY 10065
2128328170
In practice since 2006 (19 years)
NPI: 1215021118 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Finger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Finger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Finger

Dr. Paul Finger is an ophthalmology specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Finger performed 3,042 Medicare services across 1,937 unique beneficiaries.

Between the years covered by Open Payments, Dr. Finger received a total of $87 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Finger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 31% volume in NY $87 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,042
Medicare services
Top 31% in NY for ophthalmology
1,937
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~160 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
575 $106 $154
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
531 $14 $22
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
420 $34 $53
Ultrasound of eye tissue and structures
A non-invasive imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
370 $57 $208
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
268 $127 $201
Eye photography
Photographic imaging of the interior structures of the eye.
186 $19 $50
Ultrasound of eye using water bath method
An ultrasound imaging test of the eye that uses a water bath technique to visualize internal eye structures.
134 $64 $111
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
119 $25 $33
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
102 $32 $55
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
98 $102 $200
New patient office visit, complex (60-74 min) 84 $193 $259
Aflibercept eye injection (Eylea) 58 $693 $2,500
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
52 $56 $100
Retinal growth destruction via radiation implant
A procedure that destroys abnormal retinal growth by implanting a radiation source.
19 $1,247 $1,632
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
14 $27 $108
Realignment of horizontal eye muscle
A surgical procedure to adjust the position or tension of the horizontal muscles that control eye movement. This is performed to correct misalignment of the eyes.
12 $205 $722
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$87
Total received (2019-2022)
Avg $44/year across 2 years
Bottom 10% in NY for ophthalmology
2
Companies
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47 (53.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$40 (46.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$47
2019
$40

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$47
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2019-2022) ›
Genentech USA, Inc.
$47
Alcon Vision LLC
$40
Top 3 companies account for 100.0% of all-time payments
Associated products mentioned in payments ›
Constellation · VABYSMO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware.

Looking for an ophthalmology specialist in New York?
Compare ophthalmologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
1,384
Per 100K population
85.0
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Finger is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Finger experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Finger performed 575 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Finger receive payments from pharmaceutical companies?
Yes. Dr. Finger received a total of $87 from 2 companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Finger's costs compare to other ophthalmologists in New York?
Dr. Finger's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Finger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →